These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 27914211)

  • 1. microRNAs in cardiovascular disease - clinical application.
    Schulte C; Karakas M; Zeller T
    Clin Chem Lab Med; 2017 May; 55(5):687-704. PubMed ID: 27914211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
    Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
    Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction.
    Schulte C; Westermann D; Blankenberg S; Zeller T
    World J Cardiol; 2015 Dec; 7(12):843-60. PubMed ID: 26730290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases.
    Sayed AS; Xia K; Salma U; Yang T; Peng J
    Heart Lung Circ; 2014 Jun; 23(6):503-10. PubMed ID: 24726001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.
    Kondkar AA; Abu-Amero KK
    Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Signature and Cardiovascular Dysfunction.
    Arunachalam G; Upadhyay R; Ding H; Triggle CR
    J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease.
    Schulte C; Molz S; Appelbaum S; Karakas M; Ojeda F; Lau DM; Hartmann T; Lackner KJ; Westermann D; Schnabel RB; Blankenberg S; Zeller T
    PLoS One; 2015; 10(12):e0145930. PubMed ID: 26720041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA and Cardiovascular Diseases.
    Çakmak HA; Demir M
    Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases.
    Li M; Zhang J
    Biomed Res Int; 2015; 2015():730535. PubMed ID: 26180810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases.
    Tijsen AJ; Pinto YM; Creemers EE
    Am J Physiol Heart Circ Physiol; 2012 Nov; 303(9):H1085-95. PubMed ID: 22942181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs: Emerging biomarkers for atrial fibrillation.
    Komal S; Yin JJ; Wang SH; Huang CZ; Tao HL; Dong JZ; Han SN; Zhang LR
    J Cardiol; 2019 Dec; 74(6):475-482. PubMed ID: 31324570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.
    Wang F; Chen C; Wang D
    Front Med; 2014 Dec; 8(4):404-18. PubMed ID: 25445171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and Cardiovascular Disease Risk.
    Searles CD
    Curr Cardiol Rep; 2024 Feb; 26(2):51-60. PubMed ID: 38206553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Biomarkers and Cardiovascular Disease: Circulating MicroRNAs.
    de Gonzalo-Calvo D; Iglesias-Gutiérrez E; Llorente-Cortés V
    Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):763-769. PubMed ID: 28623159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts.
    Schulte C; Zeller T
    Cardiovasc Diagn Ther; 2015 Feb; 5(1):17-36. PubMed ID: 25774345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNAs as biomarkers of atrial fibrillation.
    Gomes da Silva AM; Silbiger VN
    Biomarkers; 2014 Dec; 19(8):631-6. PubMed ID: 25171770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miRNAs as biomarkers in cardiovascular diseases.
    Kaneto CM; Nascimento JS; Prado MSJG; Mendonça LSO
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2234-2243. PubMed ID: 30915771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of radiotherapy on the expression of cardiovascular disease-related miRNA-146a, -155, -221 and -222 in blood of women with breast cancer.
    Esplugas R; Arenas M; Serra N; Bellés M; Bonet M; Gascón M; Vallvé JC; Linares V
    PLoS One; 2019; 14(5):e0217443. PubMed ID: 31150454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating MicroRNAs as Potential Biomarkers of Atrial Fibrillation.
    da Silva AM; de Araújo JN; de Freitas RC; Silbiger VN
    Biomed Res Int; 2017; 2017():7804763. PubMed ID: 28349066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.